Today’s drug discovery teams face increasing pressure to accelerate timelines, improve translational success, and minimise costly clinical failures. Yet most platforms still rely on fragmented technologies that deliver partial or delayed insights—forcing you to reconstruct biology from disconnected data.

AVITI24™ 5D multiomics platform offers a new path by capturing RNA, protein, morphology, spatial resolution, and dynamic changes—all in a streamlined, customisable workflow.

Download the whitepaper to explore:

• How 5D multiomics accelerates hit identification, target and biomarker discovery, and mechanism of action studies
• Case studies on TKI resistance and CRISPR screening using AVITI24 and Direct in Sample Sequencing (DISS)
• How AVITI24 saves time, reduces risk, and improves efficiency

Brought to you by